Joseph H Capper's most recent trade in Anika Therapeutics Inc. was a trade of 14,164 Common Stock done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc. | Joseph H. Capper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 14,164 | 20,403 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.34 per share. | 02 May 2025 | 200,000 | 529,530 (0%) | 0% | 6.3 | 1,268,000 | Common Stock |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 223,268 | 329,530 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 177,364 | 3,777,364 | - | - | Stock Options | |
| Anika Therapeutics Inc. | Joseph H. Capper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 5,771 | 6,239 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Joseph H. Capper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 468 | 468 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.33 per share. | 22 Jun 2023 | 57,975 | 57,975 (0%) | 0% | 6.3 | 367,103 | Common Stock |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 22 Jun 2023 | 42,025 | 100,000 (0%) | 0% | 6.5 | 273,331 | Common Stock |
| Neuronetics Inc | Joseph H. Capper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 36,364 | 43,147 (0%) | 0% | - | Common Stock | |
| Mimedx Group Inc | Joseph H. Capper | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 3,600,000 | 3,600,000 | - | - | Stock Options | |
| Neuronetics Inc | Joseph H. Capper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 5,783 | 6,783 (0%) | 0% | 0 | Common Stock |